Acrizanib, also known as LHA510, is a potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor.
For research use only. We do not sell to patients.
Name | Acrizanib |
---|---|
Iupac Chemical Name | 5-({6-[(methylamino)methyl]pyrimidin-4-yl}oxy)-N-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]-1H-indole-1-carboxamide |
Synonyms | Acrizanib; LHA510; LHA 510; LHA-510. |
Molecular Formula | C20H18F3N7O2 |
Molecular Weight | 445.4062 |
Smile | O=C(N1C=CC2=C1C=CC(OC3=NC=NC(CNC)=C3)=C2)NC4=NN(C)C(C(F)(F)F)=C4 |
InChiKey | XPIHPLVWOUDMPF-UHFFFAOYSA-N |
InChi | InChI=1S/C20H18F3N7O2/c1-24-10-13-8-18(26-11-25-13)32-14-3-4-15-12(7-14)5-6-30(15)19(31)27-17-9-16(20(21,22)23)29(2)28-17/h3-9,11,24H,10H2,1-2H3,(H,27,28,31) |
CAS Number | 1229453-99-9 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | >98% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |